Allogene Therapeutics
Juliette Williams is an experienced program management and operations professional with a strong background in the biopharmaceutical industry and military logistics. At Allogene Therapeutics, Juliette held multiple Associate Director roles in Program Management, Network Planning and Sourcing and Supplier Management, and External Manufacturing from February 2020 to April 2024. Prior experience includes serving as a Project Management Consultant at Integrated Project Management Company, Inc., where Juliette developed integrated project plans for biologic and cell-therapy drugs. Juliette's military experience includes serving as a Medical Logistics Manager and Resource Advisor for the United States Air Force, supervising teams and managing significant medical resources. Educational qualifications include an MBA from Webster University and a BS in Business Administration from the United States Air Force Academy.
This person is not in any teams
This person is not in any offices
Allogene Therapeutics
1 followers
Allogene Therapeutics is a clinical-stage biotechnology company pioneering the development of allogeneic chimeric antigen receptor T cell (AlloCAR T™) therapies for cancer. The goal of our allogeneic cell therapy platform is simple: take the same biological processes that allow the first generation autologous CAR T therapies to deliver breakthrough clinical benefits but eliminate the need to create a personalized therapy for each patient. Instead, we start with T cells from healthy donors, which is intended to allow for creation of inventory for “off-the-shelf” use in patients faster, more reliably, and at greater scale.